Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76,399Revenue (TTM) $M9,687Net Margin (%)17.4Altman Z-Score3.6
Enterprise Value $M84,960EPS (TTM) $2.1Operating Margin %24.8Piotroski F-Score5
P/E(ttm)47.6Beneish M-Score-2.3Pre-tax Margin (%)21.9Higher ROA y-yN
Price/Book15.110-y EBITDA Growth Rate %--Quick Ratio4.3Cash flow > EarningsY
Price/Sales8.35-y EBITDA Growth Rate %19.3Current Ratio4.6Lower Leverage y-yN
Price/Free Cash Flow35.0y-y EBITDA Growth Rate %-11.4ROA % (ttm)7.3Higher Current Ratio y-yN
Dividend Yield %--PEG2.4ROE % (ttm)28.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M775ROIC % (ttm)18.7Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGJulian Robertson 2016-03-31 Buy 5.74%$96.69 - $119.76
($103.22)
$ 98.63-4%New holding228,840
CELGJoel Greenblatt 2016-03-31 Buy 0.08%$96.69 - $119.76
($103.22)
$ 98.63-4%New holding68,917
CELGKen Fisher 2016-03-31 Reduce-0.01%$96.69 - $119.76
($103.22)
$ 98.63-4%Reduce -19.27%198,160
CELGMario Gabelli 2016-03-31 Reduce$96.69 - $119.76
($103.22)
$ 98.63-4%Reduce -7.26%27,144
CELGJoel Greenblatt 2015-12-31 Sold Out -0.01%$106.55 - $127.2
($115.78)
$ 98.63-15%Sold Out0
CELGKen Fisher 2015-12-31 Add$106.55 - $127.2
($115.74)
$ 98.63-15%Add 0.37%245,460
CELGMario Gabelli 2015-12-31 Reduce$106.55 - $127.2
($115.78)
$ 98.63-15%Reduce -0.19%29,270
CELGKen Heebner 2015-09-30 Sold Out -0.36%$104.79 - $139.01
($124.1)
$ 98.63-21%Sold Out0
CELGJoel Greenblatt 2015-09-30 Reduce$104.79 - $139.01
($124.1)
$ 98.63-21%Reduce -18.44%6,344
CELGMario Gabelli 2015-09-30 Add$104.79 - $139.01
($124.1)
$ 98.63-21%Add 20.85%29,325
CELGKen Fisher 2015-09-30 Add$104.79 - $139.01
($124.1)
$ 98.63-21%Add 8.99%244,564
CELGRonald Muhlenkamp 2015-06-30 Sold Out -2.08%$107.54 - $120.34
($114.34)
$ 98.63-14%Sold Out0
CELGKen Heebner 2015-06-30 Buy 0.36%$107.54 - $120.34
($114.34)
$ 98.63-14%New holding110,000
CELGJoel Greenblatt 2015-06-30 Reduce-0.01%$107.54 - $120.34
($114.34)
$ 98.63-14%Reduce -56.76%7,778
CELGMario Gabelli 2015-06-30 Reduce$107.54 - $120.34
($114.34)
$ 98.63-14%Reduce -2.71%24,265
CELGKen Fisher 2015-06-30 Reduce$107.54 - $120.34
($114.34)
$ 98.63-14%Reduce -2.40%224,399
CELGRonald Muhlenkamp 2015-03-31 Reduce-0.02%$110.51 - $128.5
($119.49)
$ 98.63-17%Reduce -0.81%85,540
CELGJoel Greenblatt 2015-03-31 Add0.01%$110.51 - $128.5
($119.49)
$ 98.63-17%Add 75.33%17,987
CELGMario Gabelli 2015-03-31 Reduce$110.51 - $128.5
($119.49)
$ 98.63-17%Reduce -0.08%24,940
CELGKen Fisher 2015-03-31 Add$110.51 - $128.5
($119.49)
$ 98.63-17%Add 1.14%229,918
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HUGIN ROBERT Jsee remarks 2016-06-20Sell75,000$100.16-1.53view
KAPLAN GILLADirector 2016-04-04Sell15,967$101.84-3.15view
BONNEY MICHAEL WDirector 2016-03-03Buy2,000$103.01-4.25view
LOUGHLIN JAMES JDirector 2016-02-22Sell2,100$104.12-5.27view
MARIO ERNESTDirector 2015-12-28Sell40,000$119.36-17.37view
CASEY MICHAEL DDirector 2015-12-23Sell20,000$122.11-19.23view
KAPLAN GILLADirector 2015-12-21Sell14,464$110.62-10.84view
KAPLAN GILLADirector 2015-09-10Sell15,000$122.45-19.45view
CASEY MICHAEL DDirector 2015-09-08Sell15,000$121.76-19view
Daniel Thomas Osee remarks 2015-08-10Sell25,578$130.82-24.61view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
Celgene: Is It a Buy? Jun 21 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Gilead and Celgene Among Biotechnology Stocks to Buy May 26 2016 
DISH Network, H&R Block, Celgene, Plum Creek Timber Log Largest Insider Sells Jan 04 2016 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
Celgene: A Primer on Growth Stock Value Investing - Part 2 Nov 13 2015 
My Top 3 Pharma Stock Picks Jun 09 2015 
10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors Jun 04 2015 
Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
Celgene’s Earnings Shine While Revenue Misses By An Inch In The First Quarter May 06 2015 

More From Other Websites
This Biotech’s Stock Just Doubled and It’s Bad News for Sanofi Jun 29 2016
Biotechs: After Brexit, Buy the Stocks and Get the Pipelines For Free Jun 28 2016
The Largest Drug Pipelines Will Surprise You Jun 27 2016
56 Stocks That Should Dodge the Worst of Brexit Jun 27 2016
Alexion Pharmaceuticals: Brexit Be Damned; Citigroup Ups to Buy Citing "Dark Sky Valuation" Jun 27 2016
Is Brexit Good for Biotech? Maybe Jun 27 2016
How Does Brexit Impact Healthcare Stocks? Jun 27 2016
Short Sellers Run for Cover From Major Biotechs Jun 27 2016
Large Biotech and Tech Highlight Insider Selling: Applied Materials, Celgene, Cisco Systems, Palo... Jun 26 2016
How Does Brexit Affect Biotech Stocks? Wall Street Weighs In Jun 24 2016
After Brexit, These Biotech Stocks Are Vulnerable To A Mighty Dollar Jun 24 2016
Biotech: Buy the Brexit Blowup? Jun 24 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)